Regeneron (REGN) Said ARCALYST Reduced Incidence of Gout Flares
Tweet Send to a Friend
Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) said ARCALYST, also known as IL-1 Trap, in a Phase 2 study of gout ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
